KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Depreciation & Amortization - Total (2022 - 2023)

AbCellera Biologics' Depreciation & Amortization - Total history spans 2 years, with the latest figure at $3.9 million for Q4 2023.

  • For the quarter ending Q4 2023, Depreciation & Amortization - Total rose 40.75% year-over-year to $3.9 million, compared with a TTM value of $3.9 million through Sep 2024, down 67.14%, and an annual FY2024 reading of $12.5 million, down 1.73% over the prior year.
  • Depreciation & Amortization - Total for Q4 2023 was $3.9 million at AbCellera Biologics, up from $3.1 million in the prior quarter.
  • The five-year high for Depreciation & Amortization - Total was $3.9 million in Q4 2023, with the low at $1.4 million in Q1 2022.